Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CDK9 | P50750 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.52 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1313384 | 1.00 | EPHX2 (0.52) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL6251503 | 1.00 | EPHX2 (0.52) | EPHX2TP53EPHX1TSHRCDK9 | |
| SCHEMBL10875104 | 0.82 | NPC1 (0.51) | EPHX2EPHX1TSHRSMN1; SMN2EGFR | |
| SCHEMBL10876998 | 0.82 | MEN1 (0.55) | TP53EPHX1TSHRSMN1; SMN2TGM2 | |
| SCHEMBL10875107 | 0.82 | NPC1 (0.51) | EPHX2EPHX1TSHRSMN1; SMN2EGFR | |
| SCHEMBL8127012 | 0.82 | ALDH1A1 (0.50) | SMN1; SMN2TGM2EGFRMMP1MMP2 | |
| SCHEMBL10012320 | 0.82 | NPC1 (0.51) | EPHX2EPHX1TSHRSMN1; SMN2EGFR | |
| SCHEMBL10876989 | 0.82 | MEN1 (0.55) | TP53EPHX1TSHRSMN1; SMN2TGM2 | |
| SCHEMBL10874264 | 0.82 | ALDH1A1 (0.54) | TP53TSHRSMN1; SMN2HSD17B10CYP1A2 | |
| SCHEMBL10874257 | 0.82 | ALDH1A1 (0.54) | TP53TSHRSMN1; SMN2HSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113912538-A | Preparation method of quinoline compound | 沈阳中化农药化工研发有限公司 | 2022-01-11 | — | — | CN | claimed |
| CN-115714235-A | Separator and battery including the same | 武汉微美新材料科技有限公司 | 2023-02-24 | — | — | CN | disclosed |
| CN-115347324-A | Ceramic coating, and diaphragm and lithium ion battery comprising same | 武汉微美新材料科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| CN-113912538-A | Preparation method of quinoline compound | 沈阳中化农药化工研发有限公司 | 2022-01-11 | — | — | CN | disclosed |
| CN-113912538-A | Preparation method of quinoline compound | 沈阳中化农药化工研发有限公司 | 2022-01-11 | — | — | CN | disclosed |
| US-8809538-B2 | Piperidine-containing compounds and use thereof | ARRAY BIOPHARMA INC. (US) | 2014-08-19 | — | — | US | disclosed |
| CN-101849302-B | Nano-graphene sheet-based composite anode composition for lithium ion battery | NANOTEK INSTRUMENTS INC | 2013-07-24 | — | — | CN | disclosed |
| US-20110275608-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2011-11-10 | — | — | US | disclosed |
| EP-2375899-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | Array Biopharma, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| CN-101849302-A | Nano-graphene sheet-based composite anode composition for lithium ion battery | NANOTEK INSTRUMENTS INC | 2010-09-29 | — | — | CN | disclosed |
| WO-2010080864-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275608-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | NOS1, NOS2, ASS1 | EPHX2 1230/4885TP53 1738/4885EPHX1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.